Anika Therapeutics Inc. (ANIK) is in the Health Care Industry

• Sort by

• Anika Therapeutics Incorporated Q4 2007 Earnings Call Transcript

  Anika Therapeutics Incorporated Q4 2007 Earnings Call Transcript

  Earnings calls 2008-03-06

  Tags: Call Transcript, Earnings, Seeking Alpha, Financial Accounting, Finance, Anika Therapeutics Inc.

Additional Resources

• Anika Therapeutics Announces Exclusive U.S. Distribution Agreement for Elevess Injectable Dermal Filler

  Anika's HA-based Dermal Filler Incorporating Lidocaine to be Distributed by Artes Medical BEDFORD, Mass. -- Anika Therapeutics, Inc. (NASDAQ:ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid HA technology, announced today that it has signed an exclusive agreement with...

  Articles 2008-07-08

• Artes Medical Broadens Product Portfolio Through Exclusive U.S. Sales and Marketing Agreement for Elevess, a New FDA-Approved Hyaluronic Acid-Based Dermal Filler

  SAN DIEGO -- Artes Medical, Inc. (Nasdaq:ARTE), a medical aesthetics company, today announced that it has entered into an exclusive U.S. sales and marketing agreement with Anika Therapeutics Inc. (Nasdaq:ANIK) for Elevess, Anika's proprietary FDA-approved hyaluronic acid HA based temporary dermal filler for the correction of facial...

  Articles 2008-07-08

• Anika Therapeutics Announces Commercial Availability of MONOVISC™ in Europe

  Unique Osteoarthritis Treatment Provides Joint Pain Relief in a Single-Injection Regimen BEDFORD, Mass. -- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid HA technology, today announced that it has begun shipping MONOVISC[TM] to Europe....

  Articles 2008-06-30

• Research and Markets: SWOT Analysis Report of Anika Therapeutics, Inc. - Medical Equipment Producers

  DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/f6d682/anika_therapeutics) has announced the addition of the "Anika Therapeutics, Inc. Healthcare - Medical Equipment SWOT Report" companyprofile to their offering. Anika Therapeutics, Inc. Healthcare - Medical Equipment SWOT Report is a comprehensive report of the company including both quantitative...

  Articles 2008-06-25

• Mergent, Inc. Announces Quarterly Rebalancing of HealthShares™ Indexes

  NEW YORK, June 17 /PRNewswire/ -- Mergent, Inc., administrator for the HealthSharesTM Indexes, a series of 20 underlying indexes for the HealthSharesTM Exchange Traded Funds, today announced the quarterly rebalancing of the Indexes. The following securities will be added and deleted in the Indexes effective before...

  Articles 2008-06-17

• Anika Therapeutics Reports Strong Revenue Growth for First Quarter 2008

  Revenues Rise 39%, with Gains Across All Product Lines Joint Health Revenues Increase by 56% on Strong Domestic and European Sales BEDFORD, Mass. -- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid ("HA") technology, today...

  Articles 2008-04-30

• Anika Therapeutics Announces Date of First Quarter 2008 Financial Results Conference Call

  BEDFORD, Mass. -- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its first-quarter 2008 financial results after the close of the market on Wednesday, April 30, 2008. The Company plans to hold a conference call the next day (Thursday, May 1) at 9:00 a.m. ET to...

  Articles 2008-04-25

• Anika Therapeutics, Inc. Renews Shareholder Rights Plan

  BEDFORD, Mass. -- Anika Therapeutics, Inc. (NASDAQ: ANIK) announced today that its Board of Directors has renewed its Shareholder Rights Plan. The renewed plan is similar to the original plan that had been in existence for 10 years and is due to expire soon. Shareholder rights plans are designed to...

  Articles 2008-04-04

• Anika Therapeutics to Present at the Cowen and Company 28th Annual Health Care Conference

  Presentation to be Webcast live at 10:15 a.m. ET on March 20 BEDFORD, Mass. -- Anika Therapeutics, Inc. (NASDAQ:ANIK) today announced that the Company is scheduled to present at the Cowen and Company 28th Annual Health Care Conference on Thursday, March 20, 2008 at 10:15 a.m. ET. The...

  Articles 2008-03-18

• Anika Therapeutics Reports Record Product Revenues for 2007

  Strong Fourth Quarter Leads to Record Revenue for 2007 Company Strengthens its Worldwide Joint Health Franchise with Recent Start of U.S. Clinical Study of MONOVISC([TM]) and Launch of ORTHOVISC([R] )mini in European Union BEDFORD, Mass. -- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for...

  Articles 2008-03-05

• Anika Therapeutics Announces Date of Fourth Quarter and Year End 2007 Financial Results Conference Call

  WOBURN, Mass. -- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its fourth-quarter and year-end fiscal 2007 financial results after the close of the market on Wednesday, March 5, 2008. The Company plans to hold a conference call the next day (Thursday, March 6) at 9:00...

  Articles 2008-02-26

• Anika Therapeutics Launches ORTHOVISC® mini in Europe

  Company Initiates Clinical Study of ORTHOVISC mini in Three EU Countries BEDFORD, Mass. -- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has launched ORTHOVISC([R]) mini in the European Union. ORTHOVISC mini is a smaller dosage indication of ORTHOVISC([R]), which has been marketed in Europe since 1996...

  Articles 2008-02-13

• Anika Therapeutics Appoints Andrew J. Carter, Ph.D., as Chief Technology Officer

  Distinguished Product Research Executive Brings 25 Years of Experience to Company WOBURN, Mass. -- Anika Therapeutics, Inc. (NASDAQ:ANIK) today announced the appointment of Andrew J. Carter, Ph.D., as chief technology officer. Dr. Carter was most recently vice president and general manager at Spine Wave, Inc., a private company...

  Articles 2008-01-29

• Anika Therapeutics Enrolls First Patient in U.S. Clinical Study for Monovisc™

  Company Commences Study of MONOVISC for Single-Injection Joint Pain Relief of Osteoarthritis in the Knee BEDFORD, Mass. -- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has enrolled the first patient in a multi-center study evaluating its single-injection osteoarthritis product, MONOVISC([TM]). The randomized, double-blind, controlled...

  Articles 2008-01-07

• Research and Markets: Study Every Aspect of Anika Therapeutics Inc with This New Product Pipeline Report

  DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c76462) has announced the addition of "Anika Therapeutics Inc - Product Pipeline Report" to their offering. The Anika Therapeutics Inc Latest Product Pipeline Report contains contact information, business summary, company details, selected financial data, detailed product pipeline (including disease...

  Articles 2007-12-06

• Anika Therapeutics and Galderma Complete Termination of License, Development and Supply Agreements

  Anika Therapeutics Reacquires Worldwide Rights to ELEVESS Brand BEDFORD, Mass. -- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that Anika and Galderma Pharma S.A. and Galderma S.A. (together, "Galderma") have closed on their agreement to terminate all license, development and supply arrangements among the companies...

  Articles 2007-12-03

• Anika Therapeutics and Galderma Agree to Terminate License, Development and Supply Agreements

  Anika Therapeutics' to Reacquire Worldwide Rights to ELEVESS Brand BEDFORD, Mass. -- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has agreed with Galderma Pharma S.A. and Galderma S.A. (together, "Galderma") to terminate its license, development and supply agreements for the ELEVESS family of...

  Articles 2007-11-20

• Anika Therapeutics Reports 33 Percent Increase in Third Quarter Product Revenues

  In Negotiation to Terminate Agreements with Galderma and Retain Worldwide Rights to ELEVESS Brand Receives European CE Mark for MONOVISC([R]) Single-Injection Osteoarthritis Product WOBURN, Mass. -- Anika Therapeutics, Inc. (Nasdaq: ANIK) today reported financial results for the third quarter ended September 30, 2007....

  Articles 2007-11-05

• Anika Therapeutics Announces Date of Third Quarter 2007 Financial Results Conference Call

  WOBURN, Mass. -- Anika Therapeutics, Inc. (Nasdaq: ANIK) today said it plans to issue its third-quarter 2007 financial results after the close of the market on Monday, November 5, 2007. The Company plans to hold a conference call the next day (Tuesday, November 6, 2007) at 9:00 a.m. ET to...

  Articles 2007-10-19